Edition:
United States

Pieris Pharmaceuticals Inc (PIRS.OQ)

PIRS.OQ on NASDAQ Stock Exchange Capital Market

2.70USD
3:59pm EST
Change (% chg)

$-0.12 (-4.26%)
Prev Close
$2.82
Open
$2.81
Day's High
$2.88
Day's Low
$2.67
Volume
74,523
Avg. Vol
110,211
52-wk High
$9.69
52-wk Low
$2.40

Chart for

About

Pieris Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company's pipeline includes immuno-oncology multi-specifics tailored for the tumor micro-environment, an inhaled Anticalin to treat uncontrolled asthma and a half-life-optimized Anticalin to treat anemia. Its Anticalins proteins are a class of low... (more)

Overall

Beta: --
Market Cap(Mil.): $276.04
Shares Outstanding(Mil.): 44.31
Dividend: --
Yield (%): --

Financials

  PIRS.OQ Industry Sector
P/E (TTM): -- 69.71 33.71
EPS (TTM): -0.71 -- --
ROI: -55.96 8.99 14.48
ROE: -132.26 10.13 15.99

Earnings vs. Estimates